IQ-AI Limited (LON:IQAI)

Market Cap	2.08M
Revenue (ttm)	750.11K
Net Income (ttm)	-327.10K
Shares Out	246.71M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,628,044
Average Volume	991,174
Open	0.8360
Previous Close	0.8450
Day's Range	0.8221 - 0.8700
52-Week Range	0.7210 - 2.1000
Beta	2.71
RSI	39.81
Earnings Date	May 2, 2025

About IQ-AI

IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company was incorporated in 1965 and is based in Saint Helier, Jersey.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1965
• Employees: 7
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IQAI

Financial Performance

In 2024, IQ-AI's revenue was 750,105, an increase of 23.09% compared to the previous year's 609,390. Losses were -327,103, -47.56% less than in 2023.